Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
Condition: ADHD Interventions: Drug: NRCT-101-SR; Drug: Placebo Sponsor: Neurocentria, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
Condition: ADHD Interventions: Drug: NRCT-101-SR; Drug: Placebo Sponsor: Neurocentria, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials